Elliot S. Vesell, MD, ScD
Vesell E.; Therapeutic Lessons from Pharmacogenetics. Ann Intern Med. 1997;126:653-655. doi: 10.7326/0003-4819-126-8-199704150-00012
Download citation file:
Published: Ann Intern Med. 1997;126(8):653-655.
Like many other drugs, mercaptopurine and azathioprine are associated with low therapeutic indices; large interindividual variations in their metabolism; and pharmacokinetic perturbation by numerous host factors, including genetic variation. Pharmacogenetics is the exploration of genetically determined alterations in a drug's usual metabolic pathway. Such alterations are often associated with the accumulation and toxicity of a drug and with shifts to different pathways that have toxic intermediates. The paper in this issue by Yates and colleagues  on the molecular diagnosis of thiopurine S-methyltransferase (TPM) deficiency as a genetic basis for mercaptopurine and azathioprine toxicity provides an opportunity to discuss several therapeutic lessons from pharmacogenetics. These lessons can be condensed into the principle that large variations among patients in drug metabolism caused by multiple genetic and environmental factors require individualization of the dosage of many drugs to avoid either toxicity or undertreatment and to optimize therapy.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Emergency Medicine, Prevention/Screening.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only